YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation
Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 30
Related Papers
miR-21: an oncomir on strike in prostate cancer
|Molecular Cancer|2010|225
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
|European Journal of Cancer|2014|67